1. Acetylation of Oleanolic Acid Dimers as a Method of Synthesis of Powerful Cytotoxic Agents.
- Author
-
Günther A, Zalewski P, Sip S, Ruszkowski P, and Bednarczyk-Cwynar B
- Subjects
- Humans, Acetylation, Cell Line, Tumor, Quantitative Structure-Activity Relationship, Antioxidants pharmacology, Antioxidants chemistry, Antioxidants chemical synthesis, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry, Antineoplastic Agents chemical synthesis, Dimerization, Cell Survival drug effects, Molecular Structure, Cytotoxins pharmacology, Cytotoxins chemistry, Cytotoxins chemical synthesis, Oleanolic Acid chemistry, Oleanolic Acid pharmacology, Oleanolic Acid chemical synthesis
- Abstract
Oleanolic acid, a naturally occurring triterpenoid compound, has garnered significant attention in the scientific community due to its diverse pharmacological properties. Continuing our previous work on the synthesis of oleanolic acid dimers (OADs), a simple, economical, and safe acetylation reaction was performed. The newly obtained derivatives (AcOADs, 3a - 3n ) were purified using two methods. The structures of all acetylated dimers ( 3a - 3n ) were determined based on spectral methods (IR, NMR). For all AcOADs ( 3a - 3n ), the relationship between the structure and the expected directions of pharmacological activity was determined using a computational method (QSAR computational analysis). All dimers were also tested for their cytotoxic activity on the SKBR-3, SKOV-3, PC-3, and U-87 cancer cell lines. HDF cell line was applied to evaluate the Selectivity Index of the tested compounds. All cytotoxic tests were performed with the application of the MTT assay. Finally, all dimers of oleanolic acid were subjected to DPPH and CUPRAC tests to evaluate their antioxidant activity. The obtained results indicate a very high level of cytotoxic activity (IC
50 for most AcOADs below 5.00 µM) and a fairly high level of antioxidant activity (Trolox equivalent in some cases above 0.04 mg/mL)., Competing Interests: The authors declare no conflicts of interest.- Published
- 2024
- Full Text
- View/download PDF